Nelson Obus's Insider Trades & SAST Disclosures
Nelson Obus's most recent trade in Lifecore Biomedical Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on July 8, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Nelson Obus.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 30,000 | 118,687 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,554 | 88,687 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,554 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 18,182 | 79,133 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 9,474 | 60,951 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 9,474 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 9,554 | 9,554 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 9.50 per share. | 04 Jun 2022 | 7,059 | 51,477 (0%) | 0% | 9.5 | 67,061 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2022 | 7,059 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 9,474 | 9,474 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 7,059 | 7,059 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 11.64 per share. | 01 Jun 2021 | 8,303 | 44,418 (0%) | 0% | 11.6 | 96,647 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 8,303 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Purchase of securities on an exchange or from another person at price $ 10.74 per share. | 11 Jan 2021 | 13,600 | 2,905,300 (9%) | 0% | 10.7 | 146,064 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Purchase of securities on an exchange or from another person at price $ 10.81 per share. | 11 Jan 2021 | 6,400 | 2,891,700 (9%) | 0% | 10.8 | 69,184 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 10.36 per share. | 15 Oct 2020 | 2,200 | 36,115 (0%) | 0% | 10.4 | 22,792 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 2,200 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Purchase of securities on an exchange or from another person at price $ 10.32 per share. | 13 Oct 2020 | 8,638 | 2,885,300 (9%) | 0% | 10.3 | 89,144 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Purchase of securities on an exchange or from another person at price $ 10.19 per share. | 13 Oct 2020 | 1,362 | 2,876,662 (9%) | 0% | 10.2 | 13,879 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 8,303 | 8,303 | - | - | Right to Buy Restricted Stock Unit (RSU) | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 10.99 per share. | 28 May 2020 | 6,000 | 33,915 (0%) | 0% | 11.0 | 65,940 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 6,000 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Purchase of securities on an exchange or from another person at price $ 10.80 per share. | 11 May 2020 | 5,000 | 2,875,300 (9%) | 0% | 10.8 | 54,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges